Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results

cture (in particular the consolidation of Zentiva in the second quarter, and the end of commercialization of Copaxone(R) by sanofi-aventis in North America effective April 1, 2008), net sales rose by 3.1%. Excluding changes in structure and at constant exchange rates, first-half net sales growth was 3.6%.


Second-quarter net sales for the Pharmaceuticals business were up 7.3% at euro 6,726 million. First-half net sales were up 3.0% at euro 13,206 million.

Flagship products

                        2009   Change at    H1     Change at
                         Q2    constant    2009    constant
                         net    exchange    net    exchange
     Millions of euros  sales    rates     sales     rates
     ----------------- ------- ---------- ------- ----------

    Lantus((R))          792     +26.0%     1,539     +26.6%
    ------------         ---     -----      -----      -----
    Lovenox((R))         780     +13.3%     1,542      +6.9%
    -------------        ---     -----      -----      ----
    Plavix((R))          704      +4.7%     1,389      +4.2%
    ------------         ---      ----      -----      ----
    Taxotere((R))        584     +10.7%     1,118      +9.5%
    --------------       ---     -----      -----      ----
    Eloxatin((R))        353      -4.3%       697      -5.7%
    --------------       ---      ----        ---      ----
    Aprovel((R))         306      -0.6%       620      +5.0%
    -------------        ---      ----        ---      ----
    Apidra((R))           35     +54.5%        66     +48.8%
    ------------          --     -----         --     -----

Net sales of Lantus((R)), the world's leading insulin brand, rose by 26% in the second quarter (to euro 792 million), in line with the first-quarter growth trend and driven largely by the SoloST

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
(Date:7/10/2014)...  Kainos Capital, a firm specializing in acquiring and ... has acquired the Slim-Fast brand from Unilever. Unilever will ... the transaction were not disclosed. Slim-Fast is ... markets ready-to-drink shakes, powders, bars and snacks to retail ... in the United Kingdom and ...
(Date:7/10/2014)... Adelaide research may help in the fight against terrorism ... tiny quantities of explosives with the use of light ... Sensors and Actuators B: Chemical , the researchers ... explosives in concentrations as low as 6.3 ppm (parts ... a few minutes. , "Traditionally explosives detection has involved ...
(Date:7/10/2014)... RICHLAND, Wash. The lithium-ion batteries that power our ... run longer on a single charge with the help ... the porous material to replace the graphite traditionally used ... more than 10 times the energy storage capacity of ... lithium-ion battery electrode was published today in Nature ...
(Date:1/15/2014)... a club sandwich at the nanoscale, National Institute ... in crafting a uniform, multi-walled carbon-nanotube-based coating that ... in upholstered furniture and other soft furnishings. , ... reduced 35 percent compared with untreated foam. As ...
Breaking Biology Technology:Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... David P. Wright, Co-Chair of the Alliance for ... testified today before the House Labor, Health and ... critical importance of developing drugs, vaccines and other ... and other catastrophic health emergencies. Effective medical countermeasures ...
... to Enable BBK Worldwide to Better Serve Asia-Pacific ... BBK Worldwide, a global leader in patient recruitment ... BBK Worldwide -- Osaka, G.K., in Osaka, Japan. ... pharmaceutical, biotechnology, and medical device companies, as well ...
... 18 Sopherion Therapeutics, LLC, a biopharmaceutical company ... therapies, announced that it completed enrollment in its ... (Myocet(TM)) in metastatic HER-2-overexpressing breast cancer. This ... lead product in combination with the current standard ...
Cached Biology Technology:Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 3Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer 2Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer 3
(Date:7/11/2014)... This news release is available in German . ... imaging is a method that uses the refraction of ... absorption. The images produced with this method are often ... The scientists in the team of Prof. Franz Pfeiffer ... X-ray imaging and therapy including X-ray phase-contrast imaging. ...
(Date:7/11/2014)... develop relationships with other group members to reduce aggression ... baboons the strategy for grooming activities shows a certain ... in the scientific journal Biology Letters . , ... not practiced without ulterior motives. To be groomed has ... while grooming another individual can provide access to infants, ...
(Date:7/11/2014)... transplantation of mesenchymal stem cells can stimulate neurogenesis in ... Alzheimer,s disease (AD) and improve tissue and function injury ... reported on the therapeutic effect of adipose-derived stem cells ... effect on oxidative injury and neurogenesis in the brain ... School of Life Sciences, Tsinghua University, China transplanted ADSCs ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2Baboons groom early in the day to get benefits later 2
... predicted that tree species will respond to global warming ... a new study of 65 different species in 31 ... Nearly 80 percent of the species aren,t yet ... staying in place -- but speeding up their life ...
... Nio Southern Oscillation (ENSO), altering the cycles of El Nio ... to Australia and many other Pacific-rim countries., New research published ... has revealed how the ENSO cycle has changed over the ... an impact on the strength and timing of El Nio ...
... of multiple sclerosis, a debilitating disease that affects up to ... researchers and medical professionals for generations. But Steven Schutzer, a ... now found an important clue why progress has been slow ... MS has focused on the wrong part of the brain. ...
Cached Biology News:Climate change may speed up forests' life cycles 2Global warming could change strength of El Niño 2Multiple sclerosis appears to originate in different part of brain than long believed 2Multiple sclerosis appears to originate in different part of brain than long believed 3
... gun system, 100-120 V, is used for ... This handheld device employs an adjustable helium ... biomaterial-coated gold microcarriers from the inner wall ... target cells. This system has a 2 ...
... Conjugated peptides, recombinant or native proteins are used ... immunization protocol optimized in time, quantity of antigen ... the use of 2 animals per protocol in ... yield on a 77-day protocol is approximately 75 ...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
... binding specificity and signaling of the members ... be modified by alternative splicing--which has important ... you can perform a classical expression profiling ... different alternatively spliced forms of the gene ...
Biology Products: